- The Supreme Court declined to review (Law360 subscription required) a First Circuit decision affirming dismissal of false advertising and consumer protection claims alleging that McNeil Nutritionals LLC misbranded Lactaid drug
DIETARY SUPPLEMENTS
FDA Publishes Draft Guidance on NDIN Master Files
Posted on
- On April 3, 2024, the U.S. Food and Drug Administration (FDA) announced the availability of a draft guidance for industry titled “New Dietary Ingredient Notification Master Files for Dietary
Reintroduced Bill Seeks Legal Pathway for CBD in Food
Posted on
- On July 20, U.S. Senators Ron Wyden, D-Ore., Rand Paul, R-Ky., and Jeff Merkley, D-Ore., and U.S. Representative Earl Blumenauer, D-Ore., reintroduced legislation, called the “Hemp Access and Consumer
FDA Webinar Reiterates a New Regulatory Pathway Created by Federal Legislation is Required for CBD
Posted on
- A high-level internal working group that FDA convened to explore potential regulatory pathways for cannabidiol (CBD) products announced by way of a January 26, 2023 statement that existing regulatory pathways
FDA Launches Dietary Supplement Ingredient Directory
Posted on
- Yesterday, FDA launched its new Dietary Supplement Ingredient Directory which contains a list of ingredients used in dietary supplements along with links to FDA’s actions and communications regarding the ingredients.
FDA Publishes List of 2023 Priority Guidance Topics
Posted on
- FDA’s Center for Food Safety and Applied Nutrition (CFSAN) and Office of Food Policy and Response (OFPR) routinely publish a list of possible new topics for guidance documents or revisions
FDA Concludes that New Regulatory Frameworks for Foods and Supplements Containing Cannabidiol are Needed, Will Work with Congress
Posted on
- Yesterday, Janet Woodcock, M.D., the Principle Deputy Commissioner for the Office of the FDA Commissioner, released a statement regarding the Agency’s approach towards cannabidiol (CBD) and its application in the
FDA Letter States that β-Nicotinamide Mononucleotide is Not Lawful Dietary Supplement
Posted on
- This past summer Inner Mongolia Kingdomway Pharmaceutical Limited (“Kingdom”) submitted a new dietary ingredient (NDI) notification to FDA for β-Nicotinamide Mononucleotide (NMN), a compound that has been touted for its
FDA Issues Warning Letters to 7 Dietary Supplement Companies for Drug Claims
Posted on
- On November 17, 2022, FDA posted warning letters to 7 companies for selling different dietary supplements with claims that caused the products to be “drugs” in violation of the Federal
…
Continue Reading FDA Issues Warning Letters to 7 Dietary Supplement Companies for Drug Claims
FDA Finalizes NAC Enforcement Discretion Guidance
Posted on
- FDA issued final guidance regarding its decision to exercise enforcement discretion with respect to the sale and distribution of dietary supplements containing N-acetyl-L-cysteine (NAC). The final guidance is substantively identical
…
Continue Reading FDA Finalizes NAC Enforcement Discretion Guidance